您的位置: 首页 > 农业专利 > 详情页

CD40 LIGAND FUSION PROTEIN VACCINE
专利权人:
SIDNEY KIMMEL CANCER CENTER
发明人:
TANG, YUCHENG,DEISSEROTH, ALBERT
申请号:
CA2628837
公开号:
CA2628837C
申请日:
2006.11.06
申请国别(地区):
CA
年份:
2018
代理人:
摘要:
Provided are methods of generating an immune response to any of variousantigens including foreign antigens such as infectious agent antigens. Ingeneral, the method comprises administering an expression vector encoding atranscription unit encoding a secretable fusion protein, the fusion proteincontaining the foreign antigen and CD40 ligand and also administering theencoded fusion protein. In another approach, an immune response to the foreignantigen is elicited using the encoded fusion protein without administering thevector. The invention methods may be used to immunize an individual against aninfectious agent such as influenza virus. Methods of obtaining an immuneresponse in older individuals also is described.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充